Illustration: Ned Shaw
 LIKE MOLECULAR TOY-MAKERS, ribozyme researchers create tools with evolutionary, diagnostic, and therapeutic applications.

Nearly 20 years ago, Tom Cech and Sidney Altman discovered that some naturally occurring RNAs could perform enzymatic reactions, earning these researchers the 1989 Nobel Prize in chemistry. Scientists have now identified several examples of RNA enzymes, or ribozymes. Most make or break the phosphodiester bonds in nucleic acid backbones, but some perform other reactions: The ribosome's peptidyl transferase center is also a ribozyme.1

What makes ribozymes particularly interesting is that they are amenable to tinkering. Creation of a protein enzyme de novo, or modification of an existing one to function in a different way, is a monumental, and often futile effort. But nucleic acids lend themselves to this type of research because they uniquely couple genotype and phenotype, says Scott Seiwert, group leader, diagnostic systems, Ribozyme Pharmaceuticals (RPI), Boulder, Colo. In...

Interested in reading more?

Magaizne Cover

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?